PF708

Shares of the micro-cap biotech Pfenex Inc (NYSE: PFNX), which pulled back ahead of the PDUFA date for its Forteo biosimilar PF708, were advancing Monday amid a positive outcome for the binary event. FDA Hurdle Crossed The FDA has approved its NDA for PF708 under the 505(b)(2) regulatory...